MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Transverse Myelitis

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Device
  • Status: Not yet recruiting
  • Study Type: Device
  • Participants: 42
  • Start Date: November 1, 2020
High Frequency Impulse Therapy for Neuropathic Pain in NMOSD
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 350
  • Start Date: October 31, 2020
Study on the Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica and Gene Polymorphism: a Cohort Study
Clinical Trial
Behavioral
  • Status: Recruiting
  • Study Type: Behavioral
  • Participants: 50
  • Start Date: September 23, 2020
Home Based Tele-exercise for People With Chronic Neurological Impairments
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 12
  • Start Date: September 22, 2020
An Open Label Clinical Trial to Evaluate the Safety and Efficacy of CT103A Cells for the Treatment of Relapsed/Refractory Antibody-associated Idiopathic Inflammatory Diseases of the Nervous System
Clinical Trial
Other
  • Status: Not yet recruiting
  • Participants: 200
  • Start Date: May 15, 2020
An Diagnostic Cohort on Applicability and Accuracy of AQP4-Immunoglobulin G Detection Kit in the Diagnosis of Neuromyelitis Optica Spectrum Disorders
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 2000
  • Start Date: April 20, 2020
Cohort Study Evaluating the Epidemiological Characteristics of Coronavirus Infection (SARS-CoV-2) in Patients With MS or NMO
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 12
  • Start Date: March 31, 2020
Safety, Tolerability, Pharmacodynamics and Efficacy of HBM9161 Weekly Subcutaneous Administration in Patients With Neuromyelitis Optica Spectrum Disorders (NMOSD) in China
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 15
  • Start Date: January 14, 2020
A Phase 2/3 Open-Label, Single-Arm Trial to Evaluate the Safety and Activity of Eculizumab in Pediatric Patients With Relapsing Neuromyelitis Optica Spectrum Disorder
Clinical Trial
Biological
  • Status: Not yet recruiting
  • Study Type: Biological
  • Participants: 9
  • Start Date: December 20, 2019
A Phase 1/2a Open-Label Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Transverse Myelitis (TM)
Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 55
  • Start Date: December 13, 2019
A Phase 3, External Placebo-Controlled, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 60
  • Start Date: December 9, 2019
Serum Neurofilaments Light Chain and GFAP (Glial Fibrillary Acidic Protein) in Atypical Idiopathic Inflammatory Demyelinating Disorders
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 48
  • Start Date: November 5, 2019
A Phase I Clinical Trial of BAT4406F Injection on the Safety, Tolerability, and Pharmacokinetics in Patients With Neuromyelitis Optica Spectrum Disorders
Showing 1–12 of 36 Clinical Trials
Next